A Study of Revaree Plus in People With Breast Cancer

This study is testing a product called Revaree Plus — a vaginal moisturizer containing hyaluronic acid — in breast cancer survivors who are experiencing vaginal dryness and discomfort due to estrogen-depleting treatments like aromatase inhibitors or tamoxifen. The goal is to see if this non-hormonal product safely relieves vaginal symptoms without affecting cancer treatment. **You may be eligible if...** - You are 18 or older - You have been diagnosed with hormone receptor-positive breast cancer (stage 0–3) at Memorial Sloan Kettering Cancer Center (MSKCC) - You have finished primary cancer treatment (surgery, chemo, or radiation) or are currently on maintenance therapy - You are currently taking an aromatase inhibitor, tamoxifen, or a related medication - You have no current signs of active disease - You are experiencing vaginal dryness or discomfort that bothers you - You can complete questionnaires in English or Spanish **You may NOT be eligible if...** - You have evidence of active or recurrent breast cancer - You are not experiencing vaginal symptoms - You cannot complete questionnaires in English or Spanish Talk to your doctor to see if this trial is right for you.